Growing the love for investing
Results 121 - 130 of 12671 : Previous 9 10 11 12 13 14 15 16 17 Next
The Next Trend in Biotech Partnerships
Biosimilar development partnerships are popping up everywhere.
Qnexa data can't be ignored.
Why the Street Should Love Life Technologies' Earnings
All cash flow is not created equal.
If You Can't Beat 'Em, Join 'Em: Amgen Goes Generic
Biosimilars are coming -- might as well get a piece of the action.
What's Up With the Back-Slapping, Sequenom?
Some sales numbers would be nice.
Let's hope next year is as productive.
The biotech is doing something right.
Dendreon 2011: Supply Constrained to Missed Guidance
A year in review for the biotech.
The Most Unlikely Rule Breaker
When it comes to social media, Microsoft is showing more smarts than its peers.
Results 121 - 130 of 12671 : Previous 9 10 11 12 13 14 15 16 17 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK